Waltham cancer biotech unveils Gilead deal — and layoffs



The company is restructuring its team and reprioritizing its resources around two of its cancer drugs — including one that just landed a deal with Gilead Sciences Inc.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *